Oxytocin Nasal Spray

Products Description

 

Oxytocin Nasal Spray is a peptide-based nasal spray formulated with Oxytocin as its active ingredient. Oxytocin is a cyclic nonapeptide hormone composed of nine amino acids, with a well-defined molecular structure and an established research background. The product is designed in a nasal spray dosage form, offering a convenient needle-free delivery format through a controlled spray device. Its performance is influenced not only by the purity and stability of the Oxytocin raw material but also by spray uniformity, formulation properties, container integrity, and storage conditions. This makes Oxytocin Nasal Spray suitable for research involving intranasal peptide delivery, Oxytocin intranasal formulation development, and related product development projects.

 

 

Quality control for Oxytocin Nasal Spray covers raw material inspection, manufacturing processes, finished product testing, and analytical evaluation. In addition to controlling the quality of the Oxytocin active ingredient, the process also considers formulation uniformity, filling consistency, and spray performance to minimize batch-to-batch variation and support full quality traceability.

Raw Material and Manufacturing Process Control

Oxytocin is the key active ingredient in the product, making raw material quality an important starting point for subsequent manufacturing. Before entering production, the raw material is reviewed and tested according to applicable quality requirements to verify its identity, purity, appearance, and other relevant quality attributes.

During manufacturing, In-process QC is used to monitor key process stages. For a nasal spray formulation, quality control may include formulation uniformity, mixing conditions, filling operations, and compatibility between the formulation and spray device. Monitoring these parameters helps identify potential process deviations at an early stage rather than relying solely on finished product testing.

Finished Product Testing and COA

Finished product testing is used to confirm whether a specific production batch meets established quality requirements. Depending on the product characteristics and applicable standards, testing may cover chemical quality, microbiological quality, residual substances, and other relevant parameters. For nasal spray products, the overall quality of the finished formulation should also be evaluated according to its dosage form and intended application.

A COA (Certificate of Analysis) records the applicable testing items, quality specifications, and actual results for a specific batch. It is an important document for B2B quality communication and batch traceability. The currently available product information for Oxytocin Nasal Spray is summarized below, while actual test results should be confirmed against the corresponding batch COA.

Laboratory and Third-Party Testing Support

The QC Lab is an important part of the internal quality management system. HPLC, GC-MS, and standardized analytical procedures can be used according to the specific testing requirements to support the evaluation of raw materials and finished products, including purity, impurities, and applicable residual substances. These activities also contribute to systematic quality documentation and batch records.

When customers require independent verification, specific analytical testing, or additional quality documentation, third-party laboratories can be involved according to project requirements. Combining internal QC with third-party testing provides a more flexible approach to quality verification for different B2B projects and can provide additional analytical data when required.

As an Oxytocin Nasal Spray Manufacturer, our manufacturing process consists of three key stages, covering peptide preparation and purification, formulation and filling, as well as process control and quality management. Each stage is designed to maintain active ingredient stability, formulation uniformity, and consistent batch quality.

1. Peptide Preparation, Purification & Filtration

Oxytocin is produced through a controlled peptide manufacturing process and undergoes purification to remove process-related impurities. Subsequent filtration and concentration adjustment help maintain solution clarity and the required active ingredient concentration while minimizing unnecessary exposure to conditions that may affect peptide stability.

2. Formulation, Homogenization, Filling & Packaging

The purified oxytocin is formulated with selected excipients according to the predefined formulation. Controlled mixing and homogenization help ensure uniform distribution of the active ingredient. The finished solution is then filtered and transferred to the filling line for controlled filling, nasal spray assembly, sealing, labeling, and final packaging.

3. Process Control, Automation & SOP Management

Critical parameters such as temperature, processing time, concentration, excipient ratios, and filtration conditions are controlled throughout manufacturing. Standardized SOPs and, where applicable, PLC-based automated control systems are used to monitor key production parameters. Batch records and in-process quality checks further support manufacturing consistency, process traceability, and industrial-scale production.These capabilities also support Oxytocin Nasal Spray bulk supply for B2B research and product development projects, subject to specific project requirements.

Oxytocin Nasal Spray Manufacturing Process

Oxytocin Peptide Preparation → Purification → Filtration → Concentration Adjustment → Formulation → Mixing & Homogenization → Final Filtration → Filling → Nasal Spray Assembly → Packaging → Final Quality Inspection